Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Histoid leprosy, an unusual variant of leprosy − review of literature

Santhanakrishnaan S, Dakshinamoorthy M. Egyptian Journal of Dermatology and Venereology. 2023; 43 (3) : 161–163.
Download PDF
Publication

An evaluation protocol of 'Replicability Model' project for detection and treatment of leprosy and related disability in Chhattisgarh, India.

Darlong J, Govindasamy K, Ilozumba O, et al. PloS one. 2023; 18 (10) : 1-11.
Download PDF
Publication

High frequency of ofloxacin resistance patterns of M. leprae from India: An indication to revisit second line anti-leprosy treatment regimen.

Chhabra S, Narang T, Sahu S, et al. Journal of global antimicrobial resistance. 2023;
Download PDF
Publication

Childhood borderline lepromatous leprosy: a case report.

Hutahaean G, Susanto M, Napitupulu T, et al. The Turkish journal of pediatrics. 2023; 65 (5) : 862-867.
Download PDF
Publication

Ticks are unlikely to play a role in leprosy transmission in the Comoros (East Africa) as they do not harbour DNA.

Krausser L, Chauvaux E, Van Dyck-Lippens M, et al. Frontiers in medicine. 2023;
Download PDF
Practical material

People-centred approach to addressing antimicrobial resistance in human health

World Health Organization . WHO core package of interventions to support national action plans. World Health Organization . 2023;
Access resource
Publication

A study on the multidisciplinary diagnostic approach of leprosy: Can we prevent the recrudescence in the post-elimination Indian scenario?

Mukherjee M, Ghatak D, Bhunia D, et al. Medknow. Journal of Family Medicine and Primary Care. 2023; 12 (9) : 2008-2013.
Download PDF
Publication

Childhood Leprosy: A 11 Year Retrospective Study at a Tertiary Care Hospital

Chodavadia N. H, Raghavon U. N, Bhuptani N. V, et al. Hind Kusht Nivaran Sangh. Indian Journal of Leprosy. 2023;
Download PDF
Publication

Role of Ultrasonography in Peripheral Nerve Involvement in Leprosy: A Cross-sectional Study

Khan I, Alvi E, Khan MN, et al. Sciencedomain International. Journal of Advances in Medicine and Medical Research. 2023; 35 (19) : 273-278.
Download PDF
Publication

Adrenal Crisis in a Leprosy Patient due to Chronic Steroid Abuse: A Life-Threatening Emergency Often Overlooked!

Sinha P, Sharma J, Sharma M, et al. Journal of Marine Medical Society. 2023;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 134
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD